Detalhe da pesquisa
1.
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Rheumatology (Oxford)
; 63(3): 639-647, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294870
2.
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
Rheumatology (Oxford)
; 63(2): 472-481, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37228011
3.
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford)
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460548
4.
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease.
Semin Respir Crit Care Med
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740369
5.
Biomarkers of fibrosis, inflammation, and extracellular matrix in the phase 3 trial of tocilizumab in systemic sclerosis.
Clin Immunol
; 254: 109695, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479123
6.
Improving outcomes in scleroderma: recent progress of cell-based therapies.
Rheumatology (Oxford)
; 62(6): 2060-2069, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36355455
7.
A data-driven approach finds RNA polymerase III antibody and tendon friction rubs as enrichment tools for early diffuse scleroderma trials.
Rheumatology (Oxford)
; 62(4): 1543-1551, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031807
8.
'I turned in my man card': a qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis.
Rheumatology (Oxford)
; 62(6): 2160-2167, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205545
9.
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.
Rheumatology (Oxford)
; 62(7): 2501-2509, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36377780
10.
Construct validity and reliability of the assessment of systemic sclerosis-associated raynaud's phenomenon (ASRAP) questionnaire.
Rheumatology (Oxford)
; 2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481713
11.
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort.
Rheumatology (Oxford)
; 62(SI): SI54-SI63, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731139
12.
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
Rheumatology (Oxford)
; 62(12): 3785-3800, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335850
13.
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
Rheumatology (Oxford)
; 62(10): 3433-3438, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37079727
14.
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Respir Res
; 24(1): 6, 2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624431
15.
The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.
Clin Exp Rheumatol
; 41(8): 1632-1638, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497718
16.
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
Am J Respir Crit Care Med
; 205(6): 674-684, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34851799
17.
HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry.
Proc Natl Acad Sci U S A
; 117(1): 552-562, 2020 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31871193
18.
Practical management of Raynaud's phenomenon - a primer for practicing physicians.
Curr Opin Rheumatol
; 34(4): 235-244, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699336
19.
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit.
Curr Opin Rheumatol
; 34(6): 357-364, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125916
20.
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Ann Rheum Dis
; 81(12): 1722-1729, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973804